Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,808.79 -12.86 -0.46%
FTSE 100 6,788.57 -15.30 -0.22%
DAX 8,445.00 -27.20 -0.32%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

CI Global Health Sciences Corporate Class

+ Add to Watchlist

U$ISHSCI:CN

35.66 USD 0.18 0.51%

As of 07:59:30 ET on 05/21/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for CI Global Health Sciences Corporate Class (U$ISHSCI)

Year To Date: +25.43% 3-Month: +15.26% 3-Year: +26.02% 52-Week Range: 22.71 - 35.72
1-Month: +6.32% 1-Year: +55.54% 5-Year: +12.89% Beta vs CXBT: 0.82

Mutual Fund Chart for U$ISHSCI

No chart data available.
  • U$ISHSCI:CN 35.66
  • 1M
  • 1Y
Interactive U$ISHSCI Chart

Previous Close

Fund Profile & Information for U$ISHSCI

CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Inception Date: 07-23-1996 Telephone: 1-800-268-9374
Managers: ANDREW WAIGHT
Web Site: www.cifunds.com

Fundamentals for U$ISHSCI

NAV (on 2013-05-21) 35.66
Assets (M) (on 2013-03-28) 112.46
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for U$ISHSCI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2012-12-14) 0.29
Dividend Yield (ttm) 0.81

Fees & Expenses for U$ISHSCI

Front Load 5.00
Back Load 5.50
Current Mgmt Fee 2.00
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.22

Top Fund Holdings for U$ISHSCI

Filing Date: 01/31/2013
Name Position Value % of Total
HealthSouth Corp 335,000 7,971,497 5.694%
Boston Scientific Corp 1,029,700 7,671,070 5.479%
Roche Holding AG 33,400 7,370,419 5.264%
BioMarin Pharmaceutical Inc 119,900 6,563,524 4.688%
Novartis AG 80,000 5,434,604 3.882%
GlaxoSmithKline PLC 232,201 5,308,931 3.792%
Patheon Inc 1,437,139 5,288,672 3.777%
Brookdale Senior Living Inc 180,000 4,848,660 3.463%
Sanofi 49,000 4,768,091 3.406%
Merck & Co Inc 110,000 4,744,642 3.389%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil